Categories
Latest Industry Intelligence
DDW has published the first of its new Guide Series, Where is the global innovation [...]
Precision medicine uses information about an individual’s genes, proteins, and environment to prevent, diagnose, and [...]
A new genetically engineered herpes virus has delivered a one-two punch against advanced cancers in initial findings from a Phase I trial. Researchers have found that RP2 – a modified version of the herpes simplex virus – showed signs of effectiveness in a quarter of patients with a range of advanced cancers. Patients on the […]
Menu ≡ ╳ 
